Filgotinib maintained a favorable safety and efficacy profile for up to 8 years among patients with RA who participated in the DARWIN 3 LTE.
The Fund invests its assets directly, or indirectly through Derivatives or Collective Investment Schemes in the following: between 30% and 70% in shares in companies which are, at the time of purchase ...
Department of Environmental Chemistry, IDAEA-CSIC, Barcelona, Catalunya 08034, Spain Department of Evolutionary Biology, Ecology and Environmental Sciences, Faculty of Biology, Universitat de ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results